Early Changes of Serum Interleukin 14α Levels Predicts the Response to Anti-PD-1 Therapy in Cancer [0.03%]
治疗前血清白细胞介素14α水平变化可预测癌症患者抗PD-1疗效
Buhai Wang,Caiyue Chen,Shiyu Jiang et al.
Buhai Wang et al.
Background: Programmed cell death-1 (PD-1) blockade has been shown to confer clinical benefit in cancer patients. Here, we assessed the level of serum interleukin 14α (IL14α) in patients receiving anti-PD-1 treatment. ...
Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway [0.03%]
Dicer通过白细胞介素-8通路抑制肝癌细胞生长
Xin Han,Jianhua Wu,Ziyue Sha et al.
Xin Han et al.
Background: Elevated level of interleukin-8 (IL-8) promotes hepatocellular carcinoma (HCC) development and contributes to poor prognosis. Previously, we have proved that Dicer inhibits HCC progression. In this study, we e...
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma [0.03%]
立体放射外科手术相关的全脑放疗对黑色素瘤颅内转移患者的影响
Holly M Thomson,Shannon P Fortin Ensign,Victoria S Edmonds et al.
Holly M Thomson et al.
Background: Radiation necrosis (RN) is a clinically relevant complication of stereotactic radiosurgery (SRS) for intracranial metastasis (ICM) treatments. Radiation necrosis development is variable following SRS. It remai...
Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma [0.03%]
以鼻型NK/T细胞淋巴瘤与弥漫大B细胞淋巴瘤的临床特点对比分析为基础探讨EB病毒在鼻型外周T细胞淋巴瘤发病中的作用
Hirotaka Tanaka,Eri Mori,Taisuke Akutsu et al.
Hirotaka Tanaka et al.
Background: Extranodal NK/T-cell lymphoma, nasal type (ENKL), is an aggressive tumour with poor prognosis. Its early diagnosis may improve the prognosis of patients; however, it is often overlooked in many cases and misdi...
Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study [0.03%]
一项关于不可切除肝细胞癌患者使用c-TACE联合索拉非尼对比单用c-TACE的疗效的回顾性研究
Shanshan Liu,Yunwei Han,Zhihong Zhang et al.
Shanshan Liu et al.
Background: Hepatocellular carcinoma (HCC) has insidious onset. Most HCC patients are in advanced stage at the time of initial diagnosis, and the treatment response is poor. The purpose of this study was to compare the cl...
Nathalie Baudoux,Alex Friedlaender,Alfredo Addeo
Nathalie Baudoux
Lung cancer remains the leading cause of cancer-related death with an incidence that continues to increase in both sexes and all ages. However, 80% to 90% of lung cancers are non-small cell lung cancer (NSCLC) and the remaining 10% to 20% a...
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer [0.03%]
二甲双胍对转移性前列腺癌患者影响的回顾性研究
Chung-Shien Lee,So Yi Lam,Angel Liu et al.
Chung-Shien Lee et al.
Introduction: Previous studies demonstrated that metformin could lead to an inhibition of proliferation of cancer cells through a shift from anabolic to catabolic metabolism. In this study, we seek to investigate the effe...
Clinical Significance of Lymphatic Infiltration Detected by Immunohistochemical Double Staining in Patients with Endometrial Cancer [0.03%]
免疫组化双染检测淋巴管浸润在子宫内膜癌中的临床意义分析
Juan Xu,Xinmei Wang,Qiuyue Du et al.
Juan Xu et al.
Background: The presence of lymph-vascular space invasion is a powerful predictor of lymph node metastasis. However, most studies do not distinguish lymph vessel invasion (LVI) and blood vessel invasion (BVI). The aim of ...
Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer [0.03%]
验证2018年FIGO分期系统对IIIC期宫颈癌患者预后预测的价值
Xingtao Long,Misi He,Lingling Yang et al.
Xingtao Long et al.
Background: Risk stratification of patients with cervical cancer accompanied by positive lymph nodes (stage IIIC) (the 2018 International Federation of Gynecology and Obstetrics [FIGO] new staging system) yields a clinica...
Understanding Financial Toxicity in Patients with Head and Neck Cancer: A Systematic Review [0.03%]
头颈部癌症患者的财务毒性系统评价： 理解财务毒性
Mattie Rosi-Schumacher,Shivam Patel,Chandat Phan et al.
Mattie Rosi-Schumacher et al.
Background: Cancer treatment often results in financial burdens for patients including healthcare costs as well as treatment-induced disability leading to "financial toxicity" (FT) and decreased quality of life. The purpo...